Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]

Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab Syndr Obes. 2014;7:15–24.There is an error in the text on page 19:“Alpha-glucosidase inhibitors are infrequently used in the treatment of T2DM.3 These...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irons BK, Minze MG
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/08917ae1df4349dfa3d15dbbe0dd603f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:08917ae1df4349dfa3d15dbbe0dd603f
record_format dspace
spelling oai:doaj.org-article:08917ae1df4349dfa3d15dbbe0dd603f2021-12-02T07:23:37ZDrug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]1178-7007https://doaj.org/article/08917ae1df4349dfa3d15dbbe0dd603f2017-10-01T00:00:00Zhttps://www.dovepress.com/corrigendum-drug-treatment-of-type-2-diabetes-mellitus-in-patient-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab Syndr Obes. 2014;7:15–24.There is an error in the text on page 19:“Alpha-glucosidase inhibitors are infrequently used in the treatment of T2DM.3 These agents competitively inhibit the absorption of alpha-glucosidase along the brush border of the small intestine, which slows gut absorption of carbohydrates and ultimately reduces post-prandial blood glucose.34–36” should read as “Alpha-glucosidase inhibitors are infrequently used in the treatment of T2DM.3 These agents competitively inhibit the degradation of complex carbohydrates along the brush border of the small intestine, which slows gut absorption of metabolized carbohydrates and ultimately reduces post-prandial blood glucose.34–36”Read the original articleIrons BKMinze MGDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 10, Pp 457-458 (2017)
institution DOAJ
collection DOAJ
language EN
topic Specialties of internal medicine
RC581-951
spellingShingle Specialties of internal medicine
RC581-951
Irons BK
Minze MG
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
description Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab Syndr Obes. 2014;7:15–24.There is an error in the text on page 19:“Alpha-glucosidase inhibitors are infrequently used in the treatment of T2DM.3 These agents competitively inhibit the absorption of alpha-glucosidase along the brush border of the small intestine, which slows gut absorption of carbohydrates and ultimately reduces post-prandial blood glucose.34–36” should read as “Alpha-glucosidase inhibitors are infrequently used in the treatment of T2DM.3 These agents competitively inhibit the degradation of complex carbohydrates along the brush border of the small intestine, which slows gut absorption of metabolized carbohydrates and ultimately reduces post-prandial blood glucose.34–36”Read the original article
format article
author Irons BK
Minze MG
author_facet Irons BK
Minze MG
author_sort Irons BK
title Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
title_short Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
title_full Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
title_fullStr Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
title_full_unstemmed Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
title_sort drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [corrigendum]
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/08917ae1df4349dfa3d15dbbe0dd603f
work_keys_str_mv AT ironsbk drugtreatmentoftype2diabetesmellitusinpatientsforwhommetforminiscontraindicatedcorrigendum
AT minzemg drugtreatmentoftype2diabetesmellitusinpatientsforwhommetforminiscontraindicatedcorrigendum
_version_ 1718399439672967168